A Clinical Study of of RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell Lymphomas
Clinical trial NCT07316920 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07316920
- Sponsor
- YANRU WANG
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-22
- Primary completion
- 2027-06-30
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.